Unterberger Sarah, Davies Kevin A, Rambhatla Srinivasa Bhargav, Sacre Sandra
Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, BN1 9PS, UK.
Immunotargets Ther. 2021 Jul 28;10:285-298. doi: 10.2147/ITT.S288547. eCollection 2021.
Rheumatoid arthritis (RA) is a progressive autoimmune disease that is characterized by inflammation of the synovial joints leading to cartilage and bone damage. The pathogenesis is sustained by the production of pro-inflammatory cytokines including tumor necrosis factor (TNF), interleukin (IL)-1 and IL-6, which can be targeted therapeutically to alleviate disease severity. Several innate immune receptors are suggested to contribute to the chronic inflammation in RA, through the production of pro-inflammatory factors in response to endogenous danger signals. Much research has focused on toll-like receptors and more recently the nucleotide-binding domain and leucine-rich repeat pyrin containing protein-3 (NLRP3) inflammasome, which is required for the processing and release of IL-1β. This review summarizes the current understanding of the potential involvement of these receptors in the initiation and maintenance of inflammation and tissue damage in RA and experimental arthritis models.
类风湿性关节炎(RA)是一种进行性自身免疫性疾病,其特征是滑膜关节炎症导致软骨和骨损伤。发病机制由包括肿瘤坏死因子(TNF)、白细胞介素(IL)-1和IL-6在内的促炎细胞因子的产生维持,这些细胞因子可作为治疗靶点以减轻疾病严重程度。有研究表明,几种先天免疫受体通过响应内源性危险信号产生促炎因子,从而导致RA的慢性炎症。许多研究集中在Toll样受体,以及最近的核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)炎性小体,IL-1β的加工和释放需要该炎性小体。本综述总结了目前对这些受体在RA和实验性关节炎模型中炎症起始和维持以及组织损伤潜在作用的理解。